W. Schopman

580 total citations
47 papers, 429 citations indexed

About

W. Schopman is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, W. Schopman has authored 47 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 10 papers in Surgery. Recurrent topics in W. Schopman's work include Parathyroid Disorders and Treatments (7 papers), Bone health and treatments (7 papers) and Thyroid Disorders and Treatments (6 papers). W. Schopman is often cited by papers focused on Parathyroid Disorders and Treatments (7 papers), Bone health and treatments (7 papers) and Thyroid Disorders and Treatments (6 papers). W. Schopman collaborates with scholars based in Netherlands and United States. W. Schopman's co-authors include W. H. L. Hackeng, R. M. Lequin, J. Silberbusch, R. J. M. Croughs, A. J. van der Lely, F. Schwarz, Hindrik Mulder, Sylvia van Buul‐Offers, Fred H. Menko and H.J. Degenhart and has published in prestigious journals such as The Lancet, The American Journal of Medicine and The Journal of Urology.

In The Last Decade

W. Schopman

40 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Schopman Netherlands 12 140 94 88 79 75 47 429
Th. Friis Denmark 12 244 1.7× 66 0.7× 60 0.7× 34 0.4× 42 0.6× 46 449
RICHARD E. GOLDSMITH United States 13 304 2.2× 78 0.8× 112 1.3× 64 0.8× 57 0.8× 25 607
Tanny Tsao United States 12 176 1.3× 209 2.2× 82 0.9× 81 1.0× 49 0.7× 27 534
H. Wernze Germany 13 110 0.8× 105 1.1× 60 0.7× 106 1.3× 34 0.5× 60 560
Herbert Gershberg United States 16 363 2.6× 152 1.6× 86 1.0× 50 0.6× 38 0.5× 40 744
June K.Y. Li China 9 202 1.4× 114 1.2× 110 1.3× 21 0.3× 81 1.1× 12 433
R U Simpson United States 11 53 0.4× 154 1.6× 56 0.6× 42 0.5× 30 0.4× 12 497
Guntram Schernthaner Austria 10 84 0.6× 73 0.8× 77 0.9× 40 0.5× 23 0.3× 14 414
Shojiro Naomi Japan 15 183 1.3× 155 1.6× 55 0.6× 64 0.8× 23 0.3× 35 622
Fisher Jw United States 11 169 1.2× 96 1.0× 74 0.8× 61 0.8× 32 0.4× 30 561

Countries citing papers authored by W. Schopman

Since Specialization
Citations

This map shows the geographic impact of W. Schopman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schopman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schopman more than expected).

Fields of papers citing papers by W. Schopman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schopman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schopman. The network helps show where W. Schopman may publish in the future.

Co-authorship network of co-authors of W. Schopman

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schopman. A scholar is included among the top collaborators of W. Schopman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schopman. W. Schopman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulder, Hindrik, W. Schopman, & A. J. van der Lely. (1991). Extrapancreatic insulin effect of glibenclamide. European Journal of Clinical Pharmacology. 40(4). 379–381. 11 indexed citations
2.
Schopman, W., et al.. (1987). Stimulation of calcitonin secretory capacity by increased serum levels of testosterone in men treated with tamoxifen. International Journal of Andrology. 10(6). 747–751. 1 indexed citations
3.
Hackeng, W. H. L., et al.. (1987). The effect of age on the renal response to PTH infusion. Calcified Tissue International. 41(5). 262–266. 2 indexed citations
4.
Mulder, Hindrik, et al.. (1986). End-organ resistance to PTH infusion in hypercalcaemic and normocalcaemic patients with solid tumours. European Journal of Endocrinology. 113(4). 543–550. 4 indexed citations
5.
Schopman, W., et al.. (1986). The Renal Sensitivity for Endogenous Parathormone in Patients with Primary Hyperparathyroidism, Vitamin D Deficiency and Renal Stones. Hormone and Metabolic Research. 18(7). 485–489. 1 indexed citations
6.
Hackeng, W. H. L., et al.. (1984). Changes in nephrogenous cyclic AMP excretion and plasma cyclic AMP following treatment of hyperthyroidism. European Journal of Endocrinology. 106(4). 477–481. 1 indexed citations
7.
Schopman, W., et al.. (1983). The need for a sufficient number of low level sera in comparisons of different serum vitamin B12 assays. Clinica Chimica Acta. 127(2). 185–195. 5 indexed citations
8.
Hackeng, W. H. L., et al.. (1982). ANALYSIS OF FACTORS IN HYPERTHYROIDISM, WHICH DETERMINE THE DURATION OF SUPPRESSIVE TREATMENT BEFORE RECOVERY OF THYROID STIMULATING HORMONE SECRETION. Clinical Endocrinology. 16(6). 575–585. 25 indexed citations
9.
Schopman, W.. (1982). Advantages of the Application of a Desk-Top Computer for Calculations in Radioimmunoassay. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 19(4). 295–301. 1 indexed citations
10.
Nicolaï, J. J., et al.. (1980). A Simple Method for the Quantification of Biliary Reflux. Scandinavian Journal of Gastroenterology. 15(7). 775–780. 9 indexed citations
11.
12.
Jonker, J.J.C., et al.. (1974). Platelet survival time in angina pectoris and hyperlipoproteinaemia. Thrombosis Research. 4(0). 65–67. 9 indexed citations
13.
Croughs, R. J. M., et al.. (1972). ACTH AND CALCITONIN SECRETING MEDULLARY CARCINOMA OF THE THYROID. Clinical Endocrinology. 1(2). 157–171. 10 indexed citations
14.
Maas, A. P. C. van der, et al.. (1972). The Influence of Acenocumarole on the Fibrinogen-turnover in Normal Subjects, Venous Thrombosis and Congestive Heart Failure. Thrombosis and Haemostasis. 28(3). 496–508.
15.
Hackeng, W. H. L., A. P. M. Schellekens, & W. Schopman. (1970). A radioimmunoassay for human calcitonin.. PubMed. 2(5). 310–1. 9 indexed citations
16.
Lequin, R. M., W. H. L. Hackeng, & W. Schopman. (1969). A RADIOIMMUNOASSAY FOR PORCINE CALCITONIN. Journal of Endocrinology. 44(2). 283–284. 3 indexed citations
17.
Touber, J. L., et al.. (1967). RAPID RISE OF INSULIN CONCENTRATION IN THE PLASMA AFTER INTRAVENOUS ADMINISTRATION OF SODIUM TOLBUTAMIDE. The Lancet. 289(7486). 361–362. 10 indexed citations
18.
19.
Schwarz, F., et al.. (1966). Serum growth hormone and energy supply in fasting obese patients. Metabolism. 15(3). 194–205. 17 indexed citations
20.
Schopman, W., et al.. (1958). SOME EXPERIENCES WITH A MODIFICATION OF THE METHOD OF REDDY, JENKINS AND THORN FOR THE QUANTITATIVE DETERMINATION OF 17,21-DIHYDROXY-20-KETOSTEROIDS IN URINE. European Journal of Endocrinology. 28(2). 153–162. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Th. Friis Breakdown of academic impact, for papers by RICHARD E. GOLDSMITH Breakdown of academic impact, for papers by Tanny Tsao Breakdown of academic impact, for papers by H. Wernze Breakdown of academic impact, for papers by Herbert Gershberg Breakdown of academic impact, for papers by June K.Y. Li Breakdown of academic impact, for papers by R U Simpson Breakdown of academic impact, for papers by Guntram Schernthaner Breakdown of academic impact, for papers by Shojiro Naomi Breakdown of academic impact, for papers by Fisher Jw
Rankless by CCL
2026